A detailed history of Sowell Financial Services LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sowell Financial Services LLC holds 4,905 shares of NBIX stock, worth $710,538. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,905
Previous 4,893 0.25%
Holding current value
$710,538
Previous $615,000 11.87%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

BUY
$123.98 - $146.67 $1,487 - $1,760
12 Added 0.25%
4,905 $688,000
Q2 2025

Jul 11, 2025

BUY
$87.54 - $128.18 $9,366 - $13,715
107 Added 2.24%
4,893 $615,000
Q1 2025

Apr 17, 2025

BUY
$107.22 - $153.29 $513,154 - $733,645
4,786 New
4,786 $529,000
Q2 2024

Aug 13, 2024

SELL
$130.86 - $143.19 $261 - $286
-2 Reduced 0.02%
10,914 $1.5 Million
Q1 2024

May 03, 2024

BUY
$130.4 - $143.74 $1.42 Million - $1.57 Million
10,916 New
10,916 $1.51 Million
Q2 2021

Aug 05, 2021

SELL
$89.43 - $102.27 $138,974 - $158,927
-1,554 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$87.57 - $119.4 $8,669 - $11,820
-99 Reduced 5.99%
1,554 $139,000
Q4 2020

Jan 13, 2021

BUY
$86.91 - $108.33 $15,817 - $19,716
182 Added 12.37%
1,653 $158,000
Q3 2020

Nov 12, 2020

SELL
$96.16 - $135.15 $40,291 - $56,627
-419 Reduced 22.17%
1,471 $141,000
Q2 2020

Aug 13, 2020

BUY
$85.09 - $130.36 $86,281 - $132,185
1,014 Added 115.75%
1,890 $231,000
Q1 2020

May 12, 2020

BUY
$75.11 - $113.76 $4,731 - $7,166
63 Added 7.75%
876 $76,000
Q4 2019

Feb 07, 2020

BUY
$86.8 - $118.57 $57,201 - $78,137
659 Added 427.92%
813 $87,000
Q3 2019

Nov 14, 2019

BUY
$83.82 - $101.5 $12,908 - $15,631
154 New
154 $14,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.